KWF Dutch Cancer Society
Overview
KWF Dutch Cancer Society is a non-profit organization in the Netherlands that funds and facilitates scientific cancer research, influences policy, and shares knowledge to reduce the impact of cancer.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GlycoTherapeutics | Feb 2023 | Grant | Lead |
| VitroScan | Sep 2023 | Grant | Lead |
| Lumox | Jul 2026 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is KWF Dutch Cancer Society based?
KWF Dutch Cancer Society is headquartered in Amsterdam, Netherlands.
When was KWF Dutch Cancer Society founded?
KWF Dutch Cancer Society was founded in 1949.
How many portfolio companies does KWF Dutch Cancer Society have?
KWF Dutch Cancer Society has 4 portfolio companies in Caplight's dataset.
What are some companies in KWF Dutch Cancer Society's portfolio?
Portfolio companies visible on Caplight include GlycoTherapeutics, VitroScan, Lumox.
What was KWF Dutch Cancer Society's most recent investment shown here?
KWF Dutch Cancer Society's most recent investment in this portfolio sample was in Lumox in 2026.
What sectors does KWF Dutch Cancer Society focus on?
KWF Dutch Cancer Society focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does KWF Dutch Cancer Society focus on?
Stage focus information for KWF Dutch Cancer Society is not publicly available.